News

Total value of the contracts for Galapagos is $1 million over 1.5 years. Galapagos’s service division, BioFocus DPI, will develop a high throughput screening assay in mouse neurons

Under the terms of the restructure, CSL will now take full control of the program, including development and commercialization of any potential drugs arising from the program. In

The Committee for Medicinal Products for Human Use’s (CHMP’s) positive opinion is based on data from the AZA-001 trial, which has demonstrated an overall survival benefit for higher-risk

The price to be paid of E48 million will be funded from existing liquidity. The closing of the transaction, expected to take place before the end of 2008,

The patent broadly protects key aspects of Compellis’ novel obesity therapeutic strategy. CP404 is a calcium channel blocker used in a nasal formulation to block olfactory activity and

The randomized, placebo-controlled, third-party double-blind, dose escalating Phase I clinical trial will study Protexia administered intramuscularly at one and two time points in healthy human volunteers. Approximately 32

The pharmaceutical development and quality analysis (PDQ) product line consists of products used for drug content uniformity and dissolution rate testing and related services. The sale is expected

Mr Handler will drive the continued development and subsequent commercialization of the company’s innovative vascular robotic system. Before joining Corindus, Mr Handler spent more than 20 years at

Under the terms of the agreement, a subsidiary of GlaxoSmithKline (GSK) will commence a tender offer to acquire all of the outstanding shares of Genelabs common stock. The